Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies-Reference-Cited by-同舟云学术

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies

Published:1998-06-30 Issue:15 Volume:41 Page:2806-2818
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dragovich Peter S.¹,Webber Stephen E.¹,Babine Robert E.¹,Fuhrman Shella A.¹,Patick Amy K.¹,Matthews David A.¹,Lee Caroline A.¹,Reich Siegfried H.¹,Prins Thomas J.¹,Marakovits Joseph T.¹,Littlefield Ethel S.¹,Zhou Ru¹,Tikhe Jayashree¹,Ford Clifford E.¹,Wallace Michael B.¹,Meador James W.¹,Ferre Rose Ann¹,Brown Edward L.¹,Binford Susan L.¹,Harr James E. V.¹,DeLisle Dorothy M.¹,Worland Stephen T.¹

Affiliation:

1. Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980068d

Reference73 articles.

1. (a) Couch, R. B. Rhinoviruses. InVirology, 2nd ed.; Fields, B. N., Knipe, D. M., Eds.; Raven Press: New York, 1990; Vol. 1, Chapter 22, pp 607−629.

2. TREATMENT OF THE PICORNA VIRUS COMMON COLD BY INHIBITORS OF VIRAL UNCOATING AND ATTACHMENT

3. RHINOVIRUS COLDS

4. (e) Gwaltney, J. M. Rhinoviruses. InViral Infections of Humans; Evans, A. S., Ed.; Plenum Publishing Corp. New York, 1982; Chapter 20, pp 491−517.

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance;Viruses;2024-09-05

2. Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19);Current Medicinal Chemistry;2024-03

3. On the origins of SARS-CoV-2 main protease inhibitors;RSC Medicinal Chemistry;2024

4. A Critical Study on Acylating and Covalent Reversible Fragment Inhibitors of SARS‐CoV‐2 Main Protease Targeting the S1 Site with Pyridine;ChemMedChem;2023-03-13

5. P₁Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of thePisoniviricetesclass;RSC Chemical Biology;2023